AG-1295

CAS No. 71897-07-9

AG-1295( NSC 380341 | Tyrphostin AG 1295 )

Catalog No. M15750 CAS No. 71897-07-9

A quinoxaline-type tyrphostin that acts as a potent and selective inhibitor of PDGFR kinase in vitro and in Swiss 3T3 cells with IC50 of 0.3-1 uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 42 Get Quote
10MG 72 Get Quote
25MG 131 Get Quote
50MG 222 Get Quote
100MG 335 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    AG-1295
  • Note
    Research use only, not for human use.
  • Brief Description
    A quinoxaline-type tyrphostin that acts as a potent and selective inhibitor of PDGFR kinase in vitro and in Swiss 3T3 cells with IC50 of 0.3-1 uM.
  • Description
    A quinoxaline-type tyrphostin that acts as a potent and selective inhibitor of PDGFR kinase in vitro and in Swiss 3T3 cells with IC50 of 0.3-1 uM; inhibits PDGF-stimulated DNA synthesis with IC50 of 2.5 uM without affecting activity of EGFR; selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine.Blood Cancer Discontinued.
  • In Vitro
    Cell Viability Assay Cell Line:Rabbit conjunctival fibroblasts cells Concentration:1 μM, 10 μM, 100 μM Incubation Time:3 days Result:Inhibited rabbit conjunctival fibroblast cell growth stimulated by PDGF-AA or PDGF-BB.
  • In Vivo
    Animal Model:Sprague-Dawley rats (240-270 g)Dosage:12 mg/kg Administration:Intraperitoneal injection; daily; for 14 or 21 days Result:Attenuated interstitial fibrosis in rat kidney after unilateral obstruction.
  • Synonyms
    NSC 380341 | Tyrphostin AG 1295
  • Pathway
    Angiogenesis
  • Target
    PDGFR
  • Recptor
    PDGFR
  • Research Area
    Cancer
  • Indication
    Blood cancer

Chemical Information

  • CAS Number
    71897-07-9
  • Formula Weight
    234.3
  • Molecular Formula
    C16H14N2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (213.40 mM)
  • SMILES
    CC1=C(C)C=C2N=CC(C3=CC=CC=C3)=NC2=C1
  • Chemical Name
    6,7-dimethyl-2-phenyl-quinoxaline

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kovalenko M, et al. Cancer Res. 1994 Dec 1;54(23):6106-14. 2. Banai S, et al. Circulation. 1998 May 19;97(19):1960-9. 3. Iwamoto H, et al. J Lab Clin Med. 2000 May;135(5):406-12. 4. Karck M, et al. Transplantation. 2002 Nov 15;74(9):1335-41.
molnova catalog
related products
  • CT52923

    CT52923 is a selective, orally active antagonist of platelet-derived growth factor receptor (PDGFR), functioning as an ATP-competitive inhibitor.

  • PP58

    PP58 is an inhibit of PDGFR, FGFR and Src family.

  • Toceranib

    Toceranib phosphate is an orally active inhibitor of tyrosine kinase (RTK) receptor, and it potently inhibits PDGFR, VEGFR, and Kit(with Kis of 5 and 6 nM for PDGFRβ and Flk-1/KDR, respectively), has antitumor and antiangiogenic activity.